Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (10027)	5/17/1999 5:22:00 AM
From: PrometheusTex	Read Replies (2) \| Respond to of 17367

Thanks George, Now I understand better why we can say that mortality has not improved. I will have to go and bother the docs again about why THEY think it has improved in the absence of new therapy and in the face of stratification as a control. My guess is that they see the improvement as I did: as a case by case question of mortality following a diagnosis. In Texas, I do not think awareness has really been pushed; but recognition and protocol in the Critical Care unit has supposedly helped a great deal. We'll see if this is true. ProTex

To: aknahow who wrote (10027)	5/17/1999 8:14:00 AM
From: Tharos	Respond to of 17367

George, Recently, we has a little girl die here in Okinawa of meningitis. The Doctors were not sure what it was and reacted too late. After that, any kid with a fever was immediately tested. This proved awkward, as we just went through a rather hard flu season. Anyway, I think if doctors are prepared to immediately jump on the problem, and are ready to suspect meningitis at the outset of treatment, this could lead to lower mortality from early treatment by keeping the patients out of the higher Glasgow scales. In other words, the mortality rate for 8s & above is the same as it always has, but early treatment is preventing many's disease from getting to that level of seriousness. Just a thought.